NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

FT is probably the best business oriented newspaper in the world. Much better than the WSJ, which has gone way down hill for obvious reasons.

Liked the article, and fairly consistent with points made here. The root cause isn’t spoofing per se, it’s the high frequency trading that’s largely unregulated. HFT is trading in ways that are impossible for humans to execute on their own, and the regs just haven’t caught up with what’s rules govern the algorithms.

Not obvious to me that NWBO will be able to overcome the deficiencies that led to the granting of the MTD in the first place. But it’s more or less a side show anyway, since by the time it takes this case to progress to a point where there might be a settlement, all the milestones (i.e., RA submissions, approvals, uplisting, partnerships, etc.,) that impact the business will be already determined, one way or another.